Robuta

https://c19early.org/admeta.html Adintrevimab for COVID-19: real-time meta-analysis of 2 studies 2 adintrevimab COVID-19 controlled studies. 43% improvement, p = 0.48. real timemeta analysisadintrevimabcovid